S100A7A anticorps (AA 41-108) (Cy5)
Aperçu rapide pour S100A7A anticorps (AA 41-108) (Cy5) (ABIN718305)
Antigène
Voir toutes S100A7A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 41-108
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from mouse S100A15
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- S100A7A (S100 Calcium Binding Protein A7A (S100A7A))
-
Autre désignation
- S100A15
-
Sujet
-
Synonyms: Gm12, S1A7f, S1a15, AY46519, S1A7L1, S1a15a, S1a17l1, Protein S1-A15A, Protein S1-A7A, S1 calcium-binding protein A15A, S1 calcium-binding protein A7A, S1a7, S1a7a
Background: Fetal ear, skin, and tongue and human cell lines. Highly up-regulated in psoriatic epidermis. Also highly expressed in the urine of bladder squamous cell carcinoma (SCC) bearing patients.
-
ID gène
- 381493
-
UniProt
- Q6S5I3
-
Pathways
- Activation of Innate immune Response, S100 Proteins
Antigène
-